Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
Optibrium Introduces the Latest Release of StarDrop™
Wednesday, October 15, 2014
StarDrop 6.0 gives researchers the freedom to explore and organise complex project data in a flexible and intuitive way.
Improving the Consistency & Efficiency of Early Drug Discovery
Wednesday, October 15, 2014
Consistency and efficiency of assays improved by using VIAFLO II pipettes and a VIAFLO ASSIST from INTEGRA.
New Analog Hot Plates & Stirrers
Tuesday, October 14, 2014
New line of multi-position stirring hot plates and stirrers features 5 or 9 stirring positions.
New Comparator Balances from Mettler Toledo
Wednesday, October 08, 2014
Increased pressure on calibration laboratories to comply with industry regulations, such as United States Pharmacopeia (USP) Chapter 41 and Good Manufacturing Practice, have led to a growing demand for weight calibration.
New Methodology for CHN Determination of Liquid Samples
Tuesday, October 07, 2014
Exeter Analytical’s application note demonstrates the utility of Model 440 CHN microanalysis system.
New SLE and SPE Automation System from Biotage - Flexible, Simple and Reliable
Saturday, October 04, 2014
New Biotage® Extrahera™ for the processing of SLE and SPE methods in both plate and column formats.
New Line of XPE Balances from Mettler Toledo
Tuesday, September 30, 2014
The new XPE balances deliver accurate, compliant results and provide users with a high level of process security, suitable for even the strictest regulations.
Routine CHN Microanalysis of Difficult Sample Types
Friday, September 12, 2014
CHN microanalysis methodologies for handling volatile liquids, air sensitive compounds and refractory materials.
Abzena Appoints Experts for Relocation to New Headquarters
Wednesday, September 10, 2014
Laboratory relocation specialist Andrew Porter Limited has completed the move of PolyTherics, a wholly owned subsidiary of Abzena, to the Babraham Research Campus in Cambridge.
Showing Results 41 - 50 of 1310
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,800+ scientific and medical posters
4,000+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!